Latest AVI Biopharma Inc. Stories
AVI BioPharma, Inc. (NASDAQ: AVII) today announced that its partner in its cardiovascular program, Global Therapeutics, the cardiology unit of Cook Medical, has received CE Mark approval for a new cobalt chromium bare metal stent.
BOSTON (Reuters) - AVI BioPharma Inc. on Friday said a drug it is developing for certain strains of flu, including avian flu, looks promising in laboratory experiments. The drug, Neugene, is at such an early stage of development that it has yet to be tested in humans.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.